Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1377971.RAUqgw4yVHDrDLPaW4C6o7_RGwAPX5w7FQPhm_xGGERG4130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1377971.RAUqgw4yVHDrDLPaW4C6o7_RGwAPX5w7FQPhm_xGGERG4130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1377971.RAUqgw4yVHDrDLPaW4C6o7_RGwAPX5w7FQPhm_xGGERG4130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1377971.RAUqgw4yVHDrDLPaW4C6o7_RGwAPX5w7FQPhm_xGGERG4130_provenance.
- NP1377971.RAUqgw4yVHDrDLPaW4C6o7_RGwAPX5w7FQPhm_xGGERG4130_assertion description "[Amphiregulin antisense oligonucleotide inhibits the growth of T3M4 human pancreatic cancer cells and sensitizes the cells to EGF receptor-targeted therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1377971.RAUqgw4yVHDrDLPaW4C6o7_RGwAPX5w7FQPhm_xGGERG4130_provenance.
- NP1377971.RAUqgw4yVHDrDLPaW4C6o7_RGwAPX5w7FQPhm_xGGERG4130_assertion evidence source_evidence_literature NP1377971.RAUqgw4yVHDrDLPaW4C6o7_RGwAPX5w7FQPhm_xGGERG4130_provenance.
- NP1377971.RAUqgw4yVHDrDLPaW4C6o7_RGwAPX5w7FQPhm_xGGERG4130_assertion SIO_000772 9247297 NP1377971.RAUqgw4yVHDrDLPaW4C6o7_RGwAPX5w7FQPhm_xGGERG4130_provenance.
- NP1377971.RAUqgw4yVHDrDLPaW4C6o7_RGwAPX5w7FQPhm_xGGERG4130_assertion wasDerivedFrom befree-2016 NP1377971.RAUqgw4yVHDrDLPaW4C6o7_RGwAPX5w7FQPhm_xGGERG4130_provenance.
- NP1377971.RAUqgw4yVHDrDLPaW4C6o7_RGwAPX5w7FQPhm_xGGERG4130_assertion wasGeneratedBy ECO_0000203 NP1377971.RAUqgw4yVHDrDLPaW4C6o7_RGwAPX5w7FQPhm_xGGERG4130_provenance.
- befree-2016 importedOn "2016-02-19" NP1377971.RAUqgw4yVHDrDLPaW4C6o7_RGwAPX5w7FQPhm_xGGERG4130_provenance.